Adaptam Therapeutics raises €3M to advance cancer immunotherapies
Adaptam Therapeutics raises €3M to advance cancer immunotherapies San Sebastián and Barcelona-based biotech Adaptam Therapeutics has raised €3 million in a pre-seed round led by Criteria Bio Ventures to develop first-in-class antibody therapies targeting immunosuppressive myeloid cells in solid tumours. The funding will allow Adaptam to advance its antibody-based programmes,


